Malignancy potential of pleomorphic xanthoastrocytomas (PXAs) has rather been an underestimated reality. We report the case of a 13-year-old boy who presented with signs of increased intracranial pressure. The child had been epileptic since the age of 2. Computed tomography and magnetic resonance scans revealed a huge left frontal mass. At surgery, a subtotal excision was accomplished. Histopathological diagnosis was anaplastic PXA (grade III; WHO, 2000). The tumor showed an increased mitotic index and minimal endothelial proliferation. The patient died 3.5 months later due to a fatal intracranial hemorrhage. A review of the entire PXA literature revealed 15 well-documented cases of PXA with subsequent malignant transformation and 11 cases of primary anaplastic PXA. The prognosis was grim for both subsets of patients. Anaplastic PXAs clearly represent the transition between the original PXA concept and lipidized giant-cell glioblastoma.

Kepes JJ, Rubinstein LJ, Eng LF: Pleomorphic xanthoastrocytoma: A distinctive meningocerebral glioma of young subjects with relatively favourable prognosis. A study of 12 cases. Cancer 1979;44:1839–1852.
Iwaki T, Fukui M, Kondo A, Matsushima T, Takeshita I: Epithelial properties of pleomorphic xanthoastrocytomas determined in ultrastructural and immunohistochemical studies. Acta Neuropathol (Berl) 1987;74:142–150.
Sugita Y, Kepes JJ, Shigemori M, Kuramoto S, Reifenberger G, Kiwit JC, Wechsler W: Pleomorphic xanthoastrocytoma with desmoplastic reaction: Angiomatous variant. Report of two cases. Clin Neuropathol 1990;9:271–278.
Özek MM, Sav A, Pamir NA, Özer AF, Özek E, Erzen C: Pleomorphic xanthoastrocytoma associated with von Recklinghausen neurofibromatosis. Childs Nerv Syst 1993;9:39–42.
Giannini C, Scheithauer BW, Burger PC, Brat DJ, Wollan PC, Lach B, O’Neill BP: Pleomorphic xanthoastrocytoma. What do we really know about it? Cancer 1999;85:2033–2045.
Pahapill PA, Ramsay DA, Del Maestro RF: Pleomorphic xanthoastrocytoma: Case report and analysis of the literature concerning the efficacy of resection and significance of necrosis. Neurosurgery 1996;38:822–829.
Weldon-Line CM, Victor TA, Groothuis DR, Vick NA: Pleomorphic xanthoastrocytoma. Ultrastructural and immunohistochemical study of a case with a rapidly fatal outcome following surgery. Cancer 1983;52:2055–2063.
Gaskill SJ, Marlin AE, Saldivar V: Glioblastoma multiforme masquerading as a pleomorphic xanthoastrocytoma. Childs Nerv Syst 1988;4:237–240.
Kepes JJ, Rubenstein LJ, Ansbacher L, Schreiber DJ: Histopathological features of recurrent pleomorphic xanthoastrocytoma: Further corroboration of the glial nature of this neoplasm: A study of 3 cases. Acta Neuropathol (Berl) 1989;78:585–593.
Allegranza A, Ferraresi S, Bruzzone M, Giombini S: Cerebromeningeal pleomorphic xanthoastrocytoma. Report on four cases: Clinical, radiologic and pathologic features (including a case with malignant evolution). Neurosurg Rev 1991;14:43–49.
Macaulay RJB, Jay V, Hoffman HJ, Becker LE: Increased mitotic activity as a negative prognostic indicator in pleomorphic xanthoastrocytoma. Case Report. J Neurosurg 1993;79:761–768.
van Roost D, Kristof R, Zentner J, Wolf HK, Schramm J: Clinical, radiological, and therapeutic features of pleomorphic xanthoastrocytoma: Report of three patients and review of the literature. J Neurol Neurosurg Psychiatry 1996;60:690–692.
Bayindir C, Balak N, Karasu A, Kasaroglu D: Anaplastic pleomorphic xanthoastrocytoma. Childs Nerv Syst 1997;13:50–56.
Tonn JC, Paulus W, Warmuth-Metz M, Schachenmayr W, Sörensen N, Roosen K: Pleomorphic xanthoastrocytoma: Report of six cases with special consideration of diagnostic and therapeutic pitfalls. Surg Neurol 1997;47:162–169.
Charbel FT: Pleomorphic xanthoastrocytoma with malignant progression. Surg Neurol 1998;50:385–386.
Leonard N, Alcutt DA, Farrell MA: Fatal pleomorphic xanthoastrocytoma with meningeal gliomatosis. Histopathology 1998;32:375–378.
Prayson RA, Morris HH 3rd: Anaplastic pleomorphic xanthoastrocytoma. Arch Pathol Lab Med 1998;122:1082–1086.
de Tella OI Jr, Herculano MA, Prandini MN, Stavale JN, Aguiar PH: Malignant transformation of pleomorphic xanthoastrocytoma. Arq Neuropsiquiatr 2003;6:104–106.
Jones MC, Drut R, Raglia G: Pleomorphic xanthoastrocytoma: A report of two cases. Pediatr Pathol 1983;1:459–467.
Goldring S, Rich KM, Picker S: Experience with gliomas in patients presenting with a chronic seizure disorder. Clin Neurosurg 1985;33:15–42.
Grant JW, Gallagher PJ: Pleomorphic xanthoastrocytoma. Immunohistochemical methods for differentiation from fibrous histiocytomas with similar morphology. Am J Surg Pathol 1986;10:336–341.
Perry A, Giannini C, Scheithauer BW, Rojiani AM, Yachnis AT, Seo IS, Johnson PC, Kho J, Shapiro S: Composite pleomorphic xanthoastrocytoma and ganglioglioma: Report of four cases and review of the literature. Am J Surg Pathol 1997;21:763–771.
Chakrabatry A, Mitchell P, Bridges LR, Franks AJ: Malignant transformation in pleomorphic xanthoastrocytoma – Report of two cases. Br J Neurosurg 1999;13:516–519.
Lubansu A, Rorive S, David P, Sariban E, Seligmann R, Brotchi J, Pirotte B: Cerebral anaplastic pleomorphic xanthoastrocytoma with meningeal dissemination at first presentation. Childs Nerv Syst 2004;20:119–122.
Lindboe CF, Cappelen J, Kepes JJ: Pleomorphic xanthoastrocytoma as a component of a cerebellar ganglioglioma: Case Report. Neurosurgery 1992;31:353–355.
Wasdahl DA, Scheithauer BW, Andrews BT, Jeffrey RA Jr: Cerebellar pleomorphic xanthoastrocytoma: Case report. Neurosurgery 1994;35:947–951.
Herpers MJ, Freling G, Beuls EA: Pleomorphic xanthoastrocytoma in the spinal cord. Case report. J Neurosurg 1994;80:564–569.
Zarate JO, Sampaolesi R: Pleomorphic xanthoastrocytoma of the retina. Am J Surg Pathol 1999;23:79–81.
Giannini C, Scheithauer BW, Lopes MBS, Hirose T, Kros JM, Vandenberg SR: Immunophenotype of pleomorphic xanthoastrocytoma. Am J Surg Pathol 2002;26:479–485.
Zorzi F, Fachetti F, Baronchelli C, Cani E: Pleomorphic xanthoastrocytoma: An immunohistochemical study of three cases. Histopathology 1992;20:267–269.
Hirose T, Giannini C, Scheithauer BW: Ultrastructural features of pleomorphic xanthoastrocytoma: A comparative study with glioblastoma multiforme. Ultrastruct Pathol 2001;25:469–478.
Scheithauer BW, Bruner JM: The ultrastructural spectrum of astrocytic neoplasms. Ultrastruct Pathol 1987;11:535–581.
Heyerdahl-Strøm E, Skellerud K: Pleomorphic xanthoastrocytoma: Report of 5 cases. Clin Neuropathol 1983;2:188–191.
Palma L, Maleci A, DiLorenzo N, Lauro GM: Pleomorphic xanthoastrocytoma with 18-year survival. Case report. J Neurosurg 1985;63:808–810.
Kawano N: Pleomorphic xanthoastrocytoma: Some new observations. Clin Neuropathol 1992;11:323–328.
Petropoulou K, Whiteman ML, Altman NR, Bruce J, Morrison G: CT and MRI of pleomorphic xanthoastrocytoma: Unusual biologic behaviour. J Comput Assist Tomogr 1995;19:860–865.
Kepes JJ: Pleomorphic xanthoastrocytoma: The birth of a diagnosis and a concept. Brain Pathol 1993;3:269–274.
Kepes JJ, Rubinstein LJ: Malignant gliomas with heavily lipidized (foamy) tumor cells: A report of three cases with immunoperoxidase study. Cancer 1981;47:2451–2459.
Kepes JJ: Glioblastoma multiforme masquerading as a pleomorphic xanthoastrocytoma. Childs Nerv Syst 1989;5:127.
Whittle IR, Gordon A, Misra BK, Shaw JF, Steers JW: Pleomorphic xanthoastrocytoma. Report of four cases. J Neurosurg 1989;70:463–468.
Kleihues P, Cavenee W: Pathology and Genetics of Tumors of the Nervous System. Lyon, International Agency for Research on Cancer, 2000, vol 253, pp 49–53.
Vajtai I, Varga Z: Prognostic markers of pleomorphic xantoastrocytoma. Histopathology 1998;33:391–395.
Paulus W, Lisle DK, Tonn JC, Wolf HK, Roggendorf W, Reeves SA, Louis DN: Molecular genetic alterations in pleomorphic xanthoastrocytoma. Acta Neuropathol (Berl) 1996;91:293–297.
Giannini C, Hebrink D, Scheithauer BW, Dei Tos AP, James CDS: Analysis of p53 mutation and expression in pleomorphic xanthoastrocytoma. Neurogenetics 2001;3:159–162.
Sugita S, Shigemori M, Okamoto K, Morimatsu M, Arakawa M, Nakayama K: Clinicopathological study of pleomorphic xanthoastrocytoma: Correlation between histological features and prognosis. Pathol Int 2000;50:703–708.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.